Home > Insider Trading > Filing (0001209191-23-045641)

Filing Details

Accession Number:: 0001209191-23-045641
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-14 16:32:21
Reporting Period:: 2022-07-29

Accepted Time:: 2023-08-14 16:32:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613780	Dbv Technologies S.a.	DBVT	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760395	Pharis Mohideen	C/O Dbv Technologies S.a. 177-181 Avenue Pierre Brossolette Montrouge I0 92120	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2022-07-29	10,000	$0.00	34,200	No	4	A	Direct
Ordinary Shares	Acquisiton	2022-11-21	17,500	$0.00	51,700	No	4	A	Direct
Ordinary Shares	Disposition	2022-11-24	1,792	$2.88	49,908	No	4	S	Direct
Ordinary Shares	Disposition	2023-05-24	469	$3.54	49,439	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Employee Stock Option (right to buy)	Acquisiton	2022-07-29	100,000	$0.00	100,000	$4.83
Ordinary Shares	Employee Stock Option (right to buy)	Acquisiton	2022-11-21	115,000	$0.00	115,000	$3.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000		2032-07-29	No	4	A	Direct
115,000		2032-11-21	No	4	A	Direct

Footnotes

The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
Represents the Issuer's ordinary shares underlying a restricted stock unit RSU award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
Shares sold to satisfy withholding tax obligations upon the the vesting of RSUs.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0409 to EURO 1.00 as of November 24, 2022.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0746 to EURO 1.00 as of May 24, 2023.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0226 to EURO 1.00 as of July 29, 2022.
25% of the shares subject to the option vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022.
25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.